1-2 of 2
Marcello Allegretti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes

Free
EMANUELE BOSI, PAOLO POZZILLI, FRANCESCO GIORGINO, EFISIO COSSU, THOMAS LINN, LUDGER ROSE, BART KEYMEULEN, SR., PIETER GILLARD, LUISA DAFFONCHIO, PIER A. RUFFINI, MARCELLO ALLEGRETTI, LORENZO PIEMONTI
Journal: Diabetes
Diabetes 2020;69(Supplement_1):249-OR
https://doi.org/10.2337/db20-249-OR
Published: 01 June 2020
View articletitled, 249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes
Journal Articles

CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice

Free
Antonio Citro, Andrea Valle, Elisa Cantarelli, Alessia Mercalli, Silvia Pellegrini, Daniela Liberati, Luisa Daffonchio, Olga Kastsiuchenka, Pier Adelchi Ruffini, Manuela Battaglia, Marcello Allegretti, Lorenzo Piemonti
Journal: Diabetes
Diabetes 2015;64(4):1329–1340
https://doi.org/10.2337/db14-0443
Published: 14 October 2014
View articletitled, CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
Open the PDF for CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice in another window
Includes: Supplementary data